Starlight Cardiovascular

Starlight Cardiovascular
Last activity: 05.10.2022
Starlight Cardiovascular is developing much needed tools and devices to treat pediatric Congenital Heart Defects (CHDs). Approximately 1.3 million babies are born each year with a CHD. Most of the tools used to treat these children were designed for adult conditions and anatomy, limiting their utility for pediatric patients. Starlight Cardiovascular is developing a portfolio of devices designed and tested specifically for pediatric CHD with the goals of improving morbidity, mortality, and access to care.
Location: United States, California, San Diego
Employees: 1-10
Total raised: $9.48M

Funding Rounds 1

DateSeriesAmountInvestorsDeal News
05.10.2022Series A$

Mentions in press and media 4

05.10.2022Starlight Cardiovascular raises $9.48M to continue developme...-connect.or...
05.10.2022Starlight Cardiovascular Raises $9.48M in Series A FinancingStarlight Cardiovascular is developing a medical device portfolio for an underserved pediatric
10.12.2021Prestigious annual pediatric medical device competition take...Washington D.C., Dec. 10, 2021 (GLOBE NEWSWIRE) -- The National Capital Consortium for Pediatric Dev...marketscre...
-Starlight Cardiovascular“Starlight Cardiovascular”fastfounde...